Vertrix Wealth Management Q1 2026 Portfolio Shift: Focus on ETFs and Healthcare Stocks

Vertrix Wealth Management's portfolio underwent notable adjustments during Q1 2026, as indicated by filings analyzed by InsiderSet. The firm demonstrated a clear focus on growth through substantial additions while strategically managing its existing positions.

Prominent Purchases: New ETF Inflows and Individual Stock Buys

Vertrix Wealth Management significantly increased its exposure to exchange-traded funds (ETFs) during the quarter. The most striking development was the complete initiation of new positions in two trusts, FLOT and SRLN, both representing 100% increases in shares held. This suggests a strong institutional interest in these specific ETFs, potentially indicating confidence in their underlying strategies or the sectors they represent.

Furthermore, Vertrix showed significant buying activity in several individual stocks and other ETFs. The firm completely bought new positions in CVS, JNJ, and INTC. Notably, the purchases in CVS (100% increase) and JNJ (873.27% increase in value, despite a slight share decrease) indicate substantial new capital allocation to healthcare sector companies.

The addition of the Vanguard Scottsdale fund (VGSH) with a 44.23% increase in shares also points towards potential interest in specific investment themes or strategies offered by these funds, although sector data for this holding is not provided.

Strategic Sales: Reducing Exposure and ETF Flows

In contrast to the inflows, Vertrix Wealth Management also demonstrated a reductionist approach during Q1 2026. The firm completely sold out its position in BK, which was categorized under Financial Services.

Additionally, there were decreases in holdings for several other assets. Shares of the Vanguard Balanced fund (SPYV) decreased by 6.84%, and shares of the Vanguard Small Cap Value fund (BSV) saw a modest reduction, though its overall portfolio weight remained stable at approximately 5.01%. The firm also partially sold holdings in AAPL (-3.24%), CSCO (-18.86%), and VUG (though VUG saw a significant share increase, its portfolio allocation decreased slightly from 0.92% to 0.81%).

Portfolio Structure and Concentration

The changes resulted in Vertrix holding 94 distinct positions this quarter, reflecting ongoing diversification efforts or adjustments across the board.

The top five holdings by weight accounted for approximately 22.6% of the total portfolio value (Vertrix Wealth Management Institutional Profile), indicating a concentrated core despite overall diversification.

The sector allocation remained broadly diversified, with Technology and Financial Services being prominent sectors. However, the firm also maintained exposure to other sectors like Healthcare (including newly added positions) and Energy (CSCO partially sold this quarter).

Data Limitations and Conclusion

This analysis is based solely on the holdings data provided by InsiderSet for Vertrix Wealth Management's portfolio as of Q1 2026. It highlights observable changes, including significant new purchases in ETFs (FLOT, SRLN) and individual stocks (CVS, JNJ, INTC), alongside reductions in some positions like BK.

Vertrix's actions suggest a dynamic investment strategy focused on capturing growth opportunities through targeted buying while managing risk by exiting certain positions. For more detailed insights into their portfolio composition or performance, further analysis and potentially direct access to the full filing would be necessary.